Manuela Amaral-do-Nascimento

Manuela Amaral-do-Nascimento

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
MAManuela Amaral-do-Nascimento
Manuela Amaral-do-Nascimento
DSDaniela Santos
Daniela Santos
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
Tiago OuteiroTiago Outeiro
Tiago Outeiro
Seed amplification assays (SAAs) enable ultrasensitive detection of misfolded α‐synuclein across biofluids and tissues. Yet, heterogeneity in protocols limits cross‐study comparability and clinical translation. Here, we review α‐synuclein SAA methods and their performance across various biological matrices. We catalog key variables (e.g., human recombinant α‐synuclein variants, buffers, salts, beads, shaking, incubation temperature) and outline pre‐analytical factors that shape outcomes. We propose a prioritized framework of key analytical and pre‐analytical variables most likely to influence assay reproducibility and clinical interpretation. We also outline minimal reporting criteria and practical quality‐control checkpoints, and recommend multicenter interlaboratory proficiency testing as essential steps to accelerate the robust clinical and research implementation of α‐synuclein SAAs.

23 April 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
Rayanne Moura do NascimentoRayanne Moura do Nascimento
Rayanne Moura do Nascimento
MAManuela Amaral-do-Nascimento
Manuela Amaral-do-Nascimento
AMAna Carolina Miceli
Ana Carolina Miceli
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
Transmissible Spongiform Encephalopathies (TSEs), including prion diseases such as Bovine Spongiform Encephalopathy (Mad Cow Disease) and variant Creutzfeldt–Jakob Disease, pose unique challenges to the scientific and medical communities due to their infectious nature, neurodegenerative effects, and the absence of a cure. Central to the progression of TSEs is the conversion of the normal cellular prion protein (PrPC) into its infectious scrapie form (PrPSc), leading to neurodegeneration through a complex interplay involving the immune system. This review elucidates the current understanding of the immune response in prion diseases, emphasizing the dual role of the immune system in both propagating and mitigating the disease through mechanisms such as glial activation, cytokine release, and blood–brain barrier dynamics. We highlight the differential cytokine profiles associated with various prion strains and stages of disease, pointing towards the potential for cytokines as biomarkers and therapeutic targets. Immunomodulatory strategies are discussed as promising avenues for mitigating neuroinflammation and delaying disease progression. This comprehensive examination of the immune response in TSEs not only advances our understanding of these enigmatic diseases but also sheds light on broader neuroinflammatory processes, offering hope for future therapeutic interventions.